Guardant Health
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
About
Guardant Health is a leading precision oncology company focused on transforming cancer management through its proprietary liquid biopsy technology. Their tests analyze circulating tumor DNA (ctDNA) from a simple blood draw to provide comprehensive genomic insights for patients with advanced cancer, enabling earlier detection, more effective treatment selection, and recurrence monitoring. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Guardant Health do?
Guardant Health is a Biotech company that offers Platform. Teams look it up for MedTech, HealthTech, Genomics. It is based in Redwood City, United States and was founded in 2012. Public records show about 4,663 people and $900M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Guardant Health raised?
Guardant Health has raised a total of $900M in funding. The most recent round on record is Post IPO.
Where is Guardant Health headquartered?
Guardant Health is headquartered in Redwood City, United States.
When was Guardant Health founded?
Guardant Health was founded in 2012.
What industry does Guardant Health operate in?
Guardant Health operates in Biotech, MedTech, HealthTech, Genomics, Oncology.
How many employees does Guardant Health have?
Guardant Health has approximately 4,663 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.